Skip to main content
Tech.euFundingExplorerBeta

Novax

Investor profile

Novax has backed 4 European tech companies across 4 funding rounds between 2019 and 2023, joining rounds totalling €50M. Most active in Software and Healthtech. Data as of Nov 2026.

Deals
4
distinct rounds
Companies
4
backed
Active span
2019–2023
5 yrs
Total round €
€50M
sum of rounds joined

Deals by year

distinct rounds / year
Novax — deals by year — interactive chart.
Data table
Novax — deals by year
20191
20212
20231

Top sectors

by deals
Novax — top sectors — interactive chart.
Data table
Novax — top sectors
Software2
Healthtech2
Cleantech1
Fintech1

Stages

by deals
Novax — stages — interactive chart.
Data table
Novax — stages
Other1
Seed1
Series B1
Series C1

Countries

by deals
Novax — countries — interactive chart.
Data table
Novax — countries
Sweden3
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Novax — 4 dealsNovaxAnthemis — 1 shared deals · click to openAnthemisArcTern Ventures — 1 shared deals · click to openArcTern VenturesAxfood — 1 shared deals · click to openAxfoodBridge Nine — 1 shared deals · click to openBridge NineCherry Ventures — 1 shared deals · click to openCherry VenturesCircularity Capital — 1 shared deals · click to openCircularity CapitalCommerzVentures — 1 shared deals · click to openCommerzVenturesIngka Investments — 1 shared deals · click to openIngka InvestmentsJonas Kamprad — 1 shared deals · click to openJonas KampradMathias Kamprad — 1 shared deals · click to openMathias KampradMustard SEED — 1 shared deals · click to openMustard SEEDNineyards Equity — 1 shared deals · click to openNineyards EquityObvious Ventures — 1 shared deals · click to openObvious Ventures

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
HedvigSweden1€39M
WinnowUK1€9.3M
ApohemSweden1€1.8M
DentechSweden1€0

Biggest deals

top 10 by amount
CompanyStageAmountDate
HedvigSeries B€39M2021-09
WinnowSeries C€9.3M2023-06
ApohemSeed€1.8M2019-10
← Back to investors